Anitha A, Rajamohan R, Murugan M, Seo J
Molecules. 2024; 29(19).
PMID: 39407710
PMC: 11477750.
DOI: 10.3390/molecules29194782.
Boczar D, Michalska K
Molecules. 2024; 29(13).
PMID: 38999108
PMC: 11243237.
DOI: 10.3390/molecules29133159.
Iduoku K, Ngongang M, Kulathunga J, Daghighi A, Casanola-Martin G, Simsek S
Foods. 2024; 13(13).
PMID: 38998653
PMC: 11241027.
DOI: 10.3390/foods13132147.
Saffarionpour S, Diosady L
Drug Deliv Transl Res. 2024; 15(1):26-65.
PMID: 38671315
DOI: 10.1007/s13346-024-01586-x.
Pashkina E, Aktanova A, Boeva O, Bykova M, Gavrilova E, Goiman E
Pharmaceutics. 2024; 16(1).
PMID: 38276497
PMC: 10820314.
DOI: 10.3390/pharmaceutics16010127.
Cyclodextrins as building blocks for new materials.
Kfoury M, Fourmentin S
Beilstein J Org Chem. 2023; 19:889-891.
PMID: 37377772
PMC: 10291238.
DOI: 10.3762/bjoc.19.66.
Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases.
Braga S
Biomolecules. 2023; 13(4).
PMID: 37189413
PMC: 10136110.
DOI: 10.3390/biom13040666.
β-Cyclodextrin Nanosponges Inclusion Compounds Associated with Silver Nanoparticles to Increase the Antimicrobial Activity of Quercetin.
Salazar Sandoval S, Bruna T, Maldonado-Bravo F, Bolanos K, Adasme-Reyes S, Riveros A
Materials (Basel). 2023; 16(9).
PMID: 37176420
PMC: 10179898.
DOI: 10.3390/ma16093538.
Tenofovir antiviral drug solubility enhancement with β-cyclodextrin inclusion complex and study of potential inhibitor against SARS-CoV-2 main protease (M).
Mohandoss S, Velu K, Stalin T, Ahmad N, Alomar S, Lee Y
J Mol Liq. 2023; 377:121544.
PMID: 36874474
PMC: 9968670.
DOI: 10.1016/j.molliq.2023.121544.
The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review.
Almeida B, Domingues C, Mascarenhas-Melo F, Silva I, Jarak I, Veiga F
Int J Mol Sci. 2023; 24(3).
PMID: 36769299
PMC: 9918006.
DOI: 10.3390/ijms24032974.
SARS-CoV-2 main protease (3CL) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking.
Mohandoss S, Sukanya R, Ganesan S, Alkallas F, Trabelsi A, V Kusmartsev F
J Mol Liq. 2022; 366:120292.
PMID: 36101854
PMC: 9458544.
DOI: 10.1016/j.molliq.2022.120292.
Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV Inhibitor.
Francese R, Cecone C, Costantino M, Hoti G, Bracco P, Lembo D
Int J Mol Sci. 2022; 23(15).
PMID: 35955832
PMC: 9369026.
DOI: 10.3390/ijms23158701.
The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection.
Barrantes F
Prog Lipid Res. 2022; 87:101166.
PMID: 35513161
PMC: 9059347.
DOI: 10.1016/j.plipres.2022.101166.
Correction: Braga et al. Cyclodextrins in Antiviral Therapeutics and Vaccines. 2021, , 409.
Braga S, Barbosa J, Santos N, El-Saleh F, Paz F
Pharmaceutics. 2022; 14(3).
PMID: 35336060
PMC: 8951304.
DOI: 10.3390/pharmaceutics14030499.
Role of Lipid Rafts in Pathogen-Host Interaction - A Mini Review.
Kulkarni R, Wiemer E, Chang W
Front Immunol. 2022; 12:815020.
PMID: 35126371
PMC: 8810822.
DOI: 10.3389/fimmu.2021.815020.
Application of Molecular Dynamics Simulations in the Analysis of Cyclodextrin Complexes.
Mazurek A, Szeleszczuk L, Gubica T
Int J Mol Sci. 2021; 22(17).
PMID: 34502331
PMC: 8431145.
DOI: 10.3390/ijms22179422.
When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications through Network Science and Text-Mining.
Rincon-Lopez J, Almanza-Arjona Y, Riascos A, Rojas-Aguirre Y
Pharmaceutics. 2021; 13(8).
PMID: 34452258
PMC: 8399453.
DOI: 10.3390/pharmaceutics13081297.
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance.
Urru S, Maines E, Campomori A, Soffiati M
Hum Vaccin Immunother. 2021; 17(11):4112-4114.
PMID: 34197272
PMC: 8827626.
DOI: 10.1080/21645515.2021.1943992.
Cyclodextrins in the antiviral therapy.
Jicsinszky L, Martina K, Cravotto G
J Drug Deliv Sci Technol. 2021; 64:102589.
PMID: 34035845
PMC: 8135197.
DOI: 10.1016/j.jddst.2021.102589.